Benzinga's Microcap Movers for Tuesday May 1, 2012
Below are highlights from Benzinga's daily coverage of microcap securities making big moves:
Eyes on the Go
Shares of Eyes on the Go (AXCG), the Brooklyn, NY provider of video and audio systems that enable users to access images over the Internet, rose 58.33% Tuesday on 119 times the average daily volume.
Eyes on the Go has entered into a partnership agreement with Tremor Video, the largest independent online video ad solutions provider to Fortune 1000 brand advertisers and top tier publishers including clients like Coca-Cola, Ford, IBM, Marriott and UPS. Eyes will integrate Tremor Video's ad technology into its GANDER.tv web site, which delivers streaming video and audio from entertainment venues. This partnership will enable GANDER.tv to monetize the videos on their site, whether viewed via the web or mobile devices.
Eyes on the Go closed at $0.10 on Tuesday.
Nephros (NEPH), the River Edge, NJ medical device company, rose 67.33% Tuesday on 47 times the average daily volume.
Nephros announced Monday the Company had received 510k clearance from the Food and Drug Administration to market its Hemodiafiltration system for the treatment of chronic renal failure when used with UF controlled dialysis machines capable of producing ultrapure dialysate in accordance with current AAMI/ANSI/ISO standards in the United States.
Nephros closed at $1.69 on Tuesday.
Shares of Nexxus Lighting (NASDAQ: NEXS), the Charlotte, NC manufacturer of LED lighting, rose 27.13% Tuesday on 4.7 times the average daily volume.
Nexxus Lighting announced Tuesday that it is exploring strategic alternatives available to the company, including a possible sale. The Board of Directors intends to consider the full range of available options. The company also announced that it has engaged Canaccord Genuity to assist in the evaluation of these options.
Nexxus Lighting closed at $0.82 on Tuesday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.